Diagnosis and Treatment of Minor Ischaemic Stroke According to the Etiology and Pathogenesis
NCT ID: NCT01665729
Last Updated: 2012-08-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2011-06-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The 2007 Korean modified TOAST type got some progress, but there exists two major disadvantages: imperfect diagnosis and pathogenesis of perforator artery infarction etiology; lack of typing according to the pathogenesis of large atherosclerotic infarction and taking measures of treatment according to the new types. Recently, domestic professor Gaoshan proposes new approach to diagnose and treat minor ischaemic stroke according to the etiology and pathogenesis of CISS typing, but the pathogenesis of hypoperfusion infarction with severe stenosis of large artery is unclear. Is it low perfusion? Or artery-artery embolization? Or both? How to distinguish the pathogenesis of branch artery disease: by atherosclerosis? Or hyalinosis? Or both? How to check the validity of clinical types? This study take different interventions according to different types and observation of the long term clinical results of intervention( mortality, recurrence rate, disability rate and rate of cerebral hemorrhage and subarachnoid hemorrhage), in order to clarify the new types can indeed solve the current problem of minor ischaemic stroke with high mortality, recurrence rate, disability rate and rate of cerebral hemorrhage and subarachnoid hemorrhage.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
artery-artery embolus
There is no hypoperfusion ( contralateral compensatory is good )
No interventions assigned to this group
Hypoperfusion
Contralateral compensatory not sufficient
No interventions assigned to this group
Hypoperfusion and embolus amotic
Hypoperfusion and embolus amotic
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. conscious patients with any of NIHSS score = 1,or
2. NIHSS ≤ 3
Exclusion Criteria
* patients With serious heart, lung, liver, kidney dysfunction or
* severe systemic complications,
* a known tumor,
* pregnancy,
* having a history of cerebral hemorrhage
20 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Li Haiyan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Li Haiyan
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhengqi Lu, prof.
Role: STUDY_CHAIR
Department of Neurology,The Third Affiliated Hospital of Sun yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology,The Third Affiliated Hospital of Sun yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhengqi Lu, prof.
Role: primary
Haiyan Li
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-2-48
Identifier Type: -
Identifier Source: org_study_id